"Granisetron" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.
| Descriptor ID |
D017829
|
| MeSH Number(s) |
D02.145.074.444 D03.383.129.539.487.350 D03.605.084.500.444 D03.633.100.449.350
|
| Concept/Terms |
Granisetron- Granisetron
- 1-Methyl-N-(endo-9-Methyl-9-Azabicyclo(3.3.1)non-3-yl)-1H-Indazole-3-Carboxamide
BRL-43694A- BRL-43694A
- BRL 43694A
- BRL43694A
- BRL-43694
- BRL 43694
- BRL43694
Granisetron Hydrochloride- Granisetron Hydrochloride
- Hydrochloride, Granisetron
- Granisetron Monohydrochloride
- Monohydrochloride, Granisetron
|
Below are MeSH descriptors whose meaning is more general than "Granisetron".
Below are MeSH descriptors whose meaning is more specific than "Granisetron".
This graph shows the total number of publications written about "Granisetron" by people in this website by year, and whether "Granisetron" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Granisetron" by people in Profiles.
-
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. 2021 Jan; 29(1):213-222.
-
Nausea and vomiting: Therapeutic orphans of pediatric oncology. Pediatr Blood Cancer. 2017 10; 64(10).
-
Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation. Bone Marrow Transplant. 2000 Jun; 25(12):1279-83.
-
Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation. Bone Marrow Transplant. 1999 Feb; 23(3):265-9.